Mount Sinai School of Medicine health news articles
Postoperative radiotherapy does not improve survival in lung cancer patientsPost-operative radiation therapy (PORT), a controversial yet frequently administered treatment for lung cancer, may not prolong life in older people with locally advanced disease.
Universal influenza vaccine possible in futureResearchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots.
New drug improves symptoms in autism disorderResearchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of Phelan McDermid Syndrome (PMS). Behavioral symptoms of PMS fall under the autism spectrum disorder category.
Fruit and vegetable may not reduce cancer riskAn analysis by Mount Sinai researchers of over eight years of dietary data from more than 400,000 people has found that the relationship between high consumption of fruits and vegetables and a reduced risk of cancer is not as strong as commonly thought.
Vioxx trial data shows early heart riskUS researchers revealed that the heart complications after taking Vioxx, the nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer Merck pulled the drug from the market.
Gene therapy promising for chronic pain reliefNow, chronic pain can be successfully treated with novel targeted gene therapy. In an effort to find a more effective treatment for chronic pain, researchers at Mount Sinai developed a gene therapy technique that simulates the pain-killing effect of opiate drugs.
Health news organizations - M Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.